 Connection
William Robinson to Middle Aged
This is a "connection" page, showing publications William Robinson has written about Middle Aged.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.706 |
|
|
|
-
Robinson WA, Carlson BC, Poppendeck H, Wanderman NR, Bunta AD, Murphy S, Sietsema DL, Daffner SD, Edwards BJ, Watts NB, Tosi LL, Anderson PA, Freedman BA. Osteoporosis-related Vertebral Fragility Fractures: A Review and Analysis of the American Orthopaedic Association's Own the Bone Database. Spine (Phila Pa 1976). 2020 Apr 15; 45(8):E430-E438.
Score: 0.044
-
Halpern AL, Torphy RJ, McCarter MD, Sciotto CG, Glode LM, Robinson WA. A familial germline mutation in KIT associated with achalasia, mastocytosis and gastrointestinal stromal tumors shows response to kinase inhibitors. Cancer Genet. 2019 04; 233-234:1-6.
Score: 0.041
-
Robinson WA, Hevesi M, Carlson BC, Schulte S, Petfield JL, Freedman BA. Spinal Fusions in Active Military Personnel: Who Gets a Lumbar Spinal Fusion in the Military and What Impact Does It Have on Service Member Retention? Mil Med. 2019 01 01; 184(1-2):e156-e161.
Score: 0.041
-
Lee H, King G, Garg K, Pan Z, Tobin J, Robinson WA. Successful treatment of disseminated Rosai-Dorfman disease with siltuximab. Haematologica. 2018 07; 103(7):e325-e328.
Score: 0.038
-
Robinson WA, Wagner ER, Cofield RH, S?nchez-Sotelo J, Sperling JW. Long-term outcomes of humeral head replacement for the treatment of osteoarthritis; a report of 44 arthroplasties with minimum 10-year follow-up. J Shoulder Elbow Surg. 2018 May; 27(5):846-852.
Score: 0.038
-
Couts KL, Bemis J, Turner JA, Bagby SM, Murphy D, Christiansen J, Hintzsche JD, Le A, Pitts TM, Wells K, Applegate A, Amato C, Multani P, Chow-Maneval E, Tentler JJ, Shellman YG, Rioth MJ, Tan AC, Gonzalez R, Medina T, Doebele RC, Robinson WA. ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms. Mol Cancer Ther. 2018 01; 17(1):222-231.
Score: 0.037
-
Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, Applegate AJ, Couts KL, Medina TM, Wells KR, Wisell JA, McCarter MD, Box NF, Shellman YG, Gonzalez RC, Lewis KD, Tentler JJ, Tan AC, Robinson WA. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma. Melanoma Res. 2017 06; 27(3):189-199.
Score: 0.036
-
Barr J, Amato CM, Robinson SE, Kounalakis N, Robinson WA. The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma. Melanoma Res. 2012 Feb; 22(1):92-5.
Score: 0.025
-
Lyle PL, Amato CM, Fitzpatrick JE, Robinson WA. Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma. Am J Surg Pathol. 2008 Jun; 32(6):858-66.
Score: 0.019
-
Swick BL, Ravdel L, Fitzpatrick JE, Robinson WA. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate. J Cutan Pathol. 2007 Apr; 34(4):324-9.
Score: 0.018
-
Pearlman NW, McCarter MD, Frank M, Hurtubis C, Merkow RP, Franklin WA, Gonzalez R, Lewis K, Roaten JB, Robinson WA. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg. 2006 Dec; 192(6):878-81.
Score: 0.018
-
Tayal S, Classen E, Bemis L, Robinson WA. C-kit expression in dedifferentiated and well-differentiated liposarcomas; immunohistochemistry and genetic analysis. Anticancer Res. 2005 May-Jun; 25(3B):2215-20.
Score: 0.016
-
Singh M, Parnes MB, Spoelstra N, Bleile MJ, Robinson WA. p16 expression in sentinel nodes with metastatic breast carcinoma: evaluation of its role in developing triaging strategies for axillary node dissection and a marker of poor prognosis. Hum Pathol. 2004 Dec; 35(12):1524-30.
Score: 0.015
-
Akturk HK, Couts KL, Baschal EE, Karakus KE, Van Gulick RJ, Turner JA, Pyle L, Robinson WA, Michels AW. Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant Melanoma. JAMA Netw Open. 2022 12 01; 5(12):e2246400.
Score: 0.013
-
DeAngelo DJ, Radia DH, George TI, Robinson WA, Quiery AT, Drummond MW, Bose P, Hexner EO, Winton EF, Horny HP, Tugnait M, Schmidt-Kittler O, Evans EK, Lin HM, Mar BG, Verstovsek S, Deininger MW, Gotlib J. Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial. Nat Med. 2021 12; 27(12):2183-2191.
Score: 0.012
-
Torphy RJ, Friedman C, Ho F, Leonard LD, Thieu D, Lewis KD, Medina TM, Robinson WA, Gonzalez RC, Stewart CL, Kounalakis N, McCarter MD, Gleisner A. Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection. Ann Surg Oncol. 2022 Feb; 29(2):806-815.
Score: 0.012
-
Holman BN, Van Gulick RJ, Amato CM, MacBeth ML, Davies KD, Aisner DL, Robinson WA, Couts KL. Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas. Melanoma Res. 2020 12; 30(6):562-573.
Score: 0.012
-
Goldstein NB, Steel A, Barbulescu CC, Koster MI, Wright MJ, Jones KL, Gao B, Ward B, Woessner B, Trottier Z, Pakieser J, Hu J, Lambert KA, Shellman YG, Fujita M, Robinson WA, Roop DR, Norris DA, Birlea SA. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling. J Invest Dermatol. 2021 03; 141(3):638-647.e13.
Score: 0.011
-
Carlson BC, Hines JT, Robinson WA, Sebastian AS, Greenwood-Quaintance KE, Patel R, Huddleston PM. Implant Sonication versus Tissue Culture for the Diagnosis of Spinal Implant Infection. Spine (Phila Pa 1976). 2020 May 01; 45(9):E525-E532.
Score: 0.011
-
Friedman C, Lyon M, Torphy RJ, Thieu D, Hosokawa P, Gonzalez R, Lewis KD, Medina TM, Rioth MJ, Robinson WA, Kounalakis N, McCarter MD, Gleisner AL. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making. J Surg Oncol. 2019 Dec; 120(7):1276-1283.
Score: 0.011
-
Mackin AG, Pecen PE, Dinsmore AL, Patnaik JL, Gonzalez R, Robinson WA, Palestine AG. Inflammatory side effects of BRAF and MEK inhibitors. Melanoma Res. 2019 10; 29(5):522-526.
Score: 0.011
-
Gibbs P, Cebon JS, Calafiore P, Robinson WA. Cardiac metastases from malignant melanoma. Cancer. 1999 Jan 01; 85(1):78-84.
Score: 0.010
-
Wyles CC, Robinson WA, Maradit-Kremers H, Houdek MT, Trousdale RT, Mabry TM. Cost and Patient Outcomes Associated With Bilateral Total Knee Arthroplasty Performed by 2-Surgeon Teams vs a Single Surgeon. J Arthroplasty. 2019 04; 34(4):671-675.
Score: 0.010
-
Tobin RP, Jordan KR, Robinson WA, Davis D, Borges VF, Gonzalez R, Lewis KD, McCarter MD. Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab. Int Immunopharmacol. 2018 Oct; 63:282-291.
Score: 0.010
-
Carlson BC, Robinson WA, Wanderman NR, Nassr AN, Huddleston PM, Yaszemski MJ, Currier BL, Jeray KJ, Kirk KL, Bunta AD, Murphy S, Patel B, Watkins CM, Sietsema DL, Edwards BJ, Tosi LL, Anderson PA, Freedman BA. The American Orthopaedic Association's Own the Bone? database: a national quality improvement project for the treatment of bone health in fragility fracture patients. Osteoporos Int. 2018 Sep; 29(9):2101-2109.
Score: 0.010
-
Johnson A, Mathai G, Robinson WA. Malignant melanoma of the perineum. J Surg Oncol. 1993 Nov; 54(3):185-9.
Score: 0.007
-
Jones TS, Jones EL, Gao D, Pearlman NW, Robinson WA, McCarter M. Management of external ear melanoma: the same or something different? Am J Surg. 2013 Sep; 206(3):307-13.
Score: 0.007
-
Jones EL, Jones TS, Pearlman NW, Gao D, Stovall R, Gajdos C, Kounalakis N, Gonzalez R, Lewis KD, Robinson WA, McCarter MD. Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg. 2013 May; 148(5):456-61.
Score: 0.007
-
Deng H, Liu J, Deng Y, Han G, Shellman YG, Robinson SE, Tentler JJ, Robinson WA, Norris DA, Wang XJ, Zhang Q. CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1. J Invest Dermatol. 2013 May; 133(5):1294-301.
Score: 0.007
-
Arora R, Robinson WA. Breast metastases from malignant melanoma. J Surg Oncol. 1992 May; 50(1):27-9.
Score: 0.006
-
Gonzalez R, Salem P, Bunn PA, Zukiwski AA, Lamb R, Benjamin RS, Spitler L, Wedel N, Robinson WA. Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial. Mol Biother. 1991 Dec; 3(4):192-6.
Score: 0.006
-
Gonzalez R, Sanchez A, Ferguson JA, Balmer C, Daniel C, Cohn A, Robinson WA. Melatonin therapy of advanced human malignant melanoma. Melanoma Res. 1991 Nov-Dec; 1(4):237-43.
Score: 0.006
-
Mughal TI, Thomas MR, Robinson WA. Role of recombinant alpha-interferon in the treatment of advanced cutaneous malignant melanoma. Oncology. 1991; 48(5):365-8.
Score: 0.006
-
Herr R, Ferguson J, Myers N, Rovira D, Robinson WA. Cigarette smoking, blast crisis, and survival in chronic myeloid leukemia. Am J Hematol. 1990 May; 34(1):1-4.
Score: 0.006
-
Robinson WA. Malignant melanoma as a model for cancer education and prevention. 1989 Harvey lecture American Association for Cancer Education. J Cancer Educ. 1990; 5(2):85-9.
Score: 0.005
-
Juhl AL, Byers TE, Robinson WA, Morelli JG, Crane LA. The anatomic distribution of melanoma and relationships with childhood nevus distribution in Colorado. Melanoma Res. 2009 Aug; 19(4):252-9.
Score: 0.005
-
Frontiera M, Murray JL, Lamki L, Thomas J, Satterlee W, Schmelter R, Rosenblum MG, Khazaeli MB, Unger MW, Robinson WA, et al. Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma. Clin Nucl Med. 1989 May; 14(5):357-66.
Score: 0.005
-
Amaria RN, Corboy JR, Finlayson CA, Robinson WA, Borges VF. Immunomodulatory therapy in multiple sclerosis and breast cancer risk: a case report and literature review. Clin Breast Cancer. 2008 Oct; 8(5):449-52.
Score: 0.005
-
Rifkin RM, Thomas MR, Mughal TI, Kaur JS, Krebs LU, Robinson WA. Malignant melanoma--profile of an epidemic. West J Med. 1988 Jul; 149(1):43-6.
Score: 0.005
-
Hoffman SJ, Robinson WA. Use of differentiation-inducing agents in the myelodysplastic syndrome and acute non-lymphocytic leukemia. Am J Hematol. 1988 Jun; 28(2):124-7.
Score: 0.005
-
Lewis KD, Robinson WA, Millward MJ, Powell A, Price TJ, Thomson DB, Walpole ET, Haydon AM, Creese BR, Roberts KL, Zalcberg JR, Gonzalez R. A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Invest New Drugs. 2008 Feb; 26(1):89-94.
Score: 0.005
-
Iyengar VG, Peterson VM, Rundus C, Robinson WA. Postburn serum inhibits in vitro production of colony-stimulating factor by mononuclear peripheral blood cells. Int J Cell Cloning. 1986 Nov; 4(6):472-82.
Score: 0.004
-
Robinson WA, Mughal TI, Thomas MR, Johnson M, Spiegel RJ. Treatment of metastatic malignant melanoma with recombinant interferon alpha 2. Immunobiology. 1986 Sep; 172(3-5):275-82.
Score: 0.004
-
Ravdel L, Robinson WA, Lewis K, Gonzalez R. Metastatic melanoma in the breast: a report of 27 cases. J Surg Oncol. 2006 Aug 01; 94(2):101-4.
Score: 0.004
-
Lewis KD, Robinson WA, McCarter M, Pearlman N, O'Day SJ, Anderson C, Amatruda TT, Baron A, Zeng C, Becker M, Dollarhide S, Matijevich K, Gonzalez R. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma. J Clin Oncol. 2006 Jul 01; 24(19):3157-63.
Score: 0.004
-
Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Kuo C, Wang HJ, Milford R, Morton DL, Hoon DS. Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res. 2006 Feb 15; 12(4):1137-43.
Score: 0.004
-
Schmelter RF, Friefeld GD, Thomas J, Robinson WA. Diagnosis of malignant melanoma with radiolabeled monoclonal antibodies: current status. Drug Intell Clin Pharm. 1986 Feb; 20(2):125-33.
Score: 0.004
-
Lewis KD, Thompson JA, Weber JS, Robinson WA, O'Day S, Lutzky J, Legha SS, Floret S, Ruvuna F, Gonzalez R. A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma. Invest New Drugs. 2006 Jan; 24(1):89-94.
Score: 0.004
-
Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Wang HJ, Elashoff RM, Takeuchi H, Umetani N, Hoon DS. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial. J Clin Oncol. 2005 Nov 01; 23(31):8057-64.
Score: 0.004
-
Wettlaufer JN, Feiner AS, Robinson WA. Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors. Cancer. 1984 Jan 15; 53(2):203-9.
Score: 0.004
-
Peterson V, Hansbrough J, Buerk C, Rundus C, Wallner S, Smith H, Robinson WA. Regulation of granulopoiesis following severe thermal injury. J Trauma. 1983 Jan; 23(1):19-24.
Score: 0.003
-
Gibbs P, Robinson WA, Pearlman N, Raben D, Walsh P, Gonzalez R. Management of primary cutaneous melanoma of the head and neck: The University of Colorado experience and a review of the literature. J Surg Oncol. 2001 Jul; 77(3):179-85; discussion 186-7.
Score: 0.003
-
Robinson WA, Hartmann DW, Mangalik A, Morton N, Joshi JH. Autologous nonfrozen bone marrow transplantation after intensive chemotherapy: a pilot study. Acta Haematol. 1981; 66(3):145-53.
Score: 0.003
-
Singer JW, Fialkow PJ, Steinmann L, Najfeld V, Stein SJ, Robinson WA. Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro. Blood. 1979 Feb; 53(2):264-8.
Score: 0.003
-
Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Bartolucci AA, Rosen L. Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial. J Am Coll Surg. 1998 Jul; 187(1):69-77; discussion 77-9.
Score: 0.002
-
Wallack MK, Sivanandham M, Ditaranto K, Shaw P, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Rosen L, Bartolucci AA. Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial. Ann Surg. 1997 Aug; 226(2):198-206.
Score: 0.002
-
Harland DL, Robinson WA, Franklin WA. Deletion of the p53 gene in a patient with aggressive burn scar carcinoma. J Trauma. 1997 Jan; 42(1):104-7.
Score: 0.002
-
Pearlman NW, Robinson WA, Dreiling LK, McIntyre RC, Gonzales R. Modified ilioinguinal node dissection for metastatic melanoma. Am J Surg. 1995 Dec; 170(6):647-9; discussion 649-50.
Score: 0.002
-
Feun LG, Robinson WA, Savaraj N, Gonzalez R, Liebmann A, Offenhauser K, Clendeninn NJ. Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma. Am J Clin Oncol. 1995 Dec; 18(6):488-90.
Score: 0.002
-
Robinson JF, Robinson WA, Cohn A, Garg K, Armstrong JD. Perforation of the great vessels during central venous line placement. Arch Intern Med. 1995 Jun 12; 155(11):1225-8.
Score: 0.002
-
Gray JL, Robinson WA. Treatment of adult acute non-lymphocytic leukemia. Rocky Mt Med J. 1975 Jan; 72(1):13-6.
Score: 0.002
-
Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty LE, Richards JM, Bartolucci AA, et al. A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma. Cancer. 1995 Jan 01; 75(1):34-42.
Score: 0.002
-
Schofield JR, Robinson WA, Murphy JR, Rovira DK. Low doses of interferon-alpha are as effective as higher doses in inducing remissions and prolonging survival in chronic myeloid leukemia. Ann Intern Med. 1994 Nov 15; 121(10):736-44.
Score: 0.002
-
Ward HP, Vautrin R, Kurnick J, Robinson WA. Presence of a myeloproliferative factor in patients with polycythemia vera and agnogenic myeloid metaplasia. I. Expansion of the erythropoietin-responsive stem cell compartment. Proc Soc Exp Biol Med. 1974 Oct; 147(1):305-8.
Score: 0.002
-
Pearlman NW, Takach TJ, Robinson WA, Ferguson J, Cohen AL. A case-control study of late recurrence of malignant melanoma. Am J Surg. 1992 Nov; 164(5):458-60; discussion 460-1.
Score: 0.002
-
Kurnick JE, Robinson WA. Combination chemotherapy of advanced lymphomas. Arch Intern Med. 1972 Jun; 129(6):908-13.
Score: 0.002
-
Sanchez A, Robinson WA, Cohn A, Gonzalez R, Adlakha A. Low-dose alpha-interferon treatment of chronic myeloid leukemia. Am J Hematol. 1992 Jan; 39(1):61-2.
Score: 0.002
-
Robinson WA, Kurnick JE, Pike BL. Colony growth of human leukemic peripheral blood cells in vitro. Blood. 1971 Oct; 38(4):500-8.
Score: 0.002
-
Feun LG, Gonzalez R, Savaraj N, Hanlon J, Collier M, Robinson WA, Clendeninn NJ. Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration. J Clin Oncol. 1991 Mar; 9(3):464-7.
Score: 0.001
-
Weiner HL, Robinson WA. Leukopoietic activity in human urine following operative procedures. Proc Soc Exp Biol Med. 1971 Jan; 136(1):29-33.
Score: 0.001
-
Brega K, Robinson WA, Winston K, Wittenberg W. Surgical treatment of brain metastases in malignant melanoma. Cancer. 1990 Nov 15; 66(10):2105-10.
Score: 0.001
-
Robinson WA, Pike BL. Leukopoietic activity in human urine. The granulocytic leukemias. N Engl J Med. 1970 Jun 04; 282(23):1291-7.
Score: 0.001
-
Elenbaas RM, Frost GL, Robinson WA, Collier RE, McNabney WK, Ryan JL, Singsank MJ. Subcutaneous epinephrine vs. nebulized metaproterenol in acute asthma. Drug Intell Clin Pharm. 1985 Jul-Aug; 19(7-8):567-71.
Score: 0.001
-
Peterson VM, Robinson WA, Wallner SF, Rundus C, Hansbrough JF. Granulocyte stem cells are decreased in humans with fatal burns. J Trauma. 1985 May; 25(5):413-8.
Score: 0.001
-
Mughal TI, Robinson WA, Padmos MA. Adult Hodgkin's disease in Saudi Arabia. Eur J Surg Oncol. 1985 Mar; 11(1):41-5.
Score: 0.001
-
Thomas MR, Robinson WA, Dantas M, Koeppler H, Drebing C, Glode LM. Autologous marrow transplantation for patients with chronic myelogenous leukemia (CML) in blast crisis. Am J Hematol. 1984 Feb; 16(2):105-12.
Score: 0.001
-
Thomas MR, Robinson WA, Boyle DJ, Day JF, Entringer MA, Steigerwald JF. Longterm effects of cyclophosphamide on granulocyte colony formation in patients with rheumatoid arthritis. J Rheumatol. 1983 Oct; 10(5):778-83.
Score: 0.001
-
Thomas MR, Robinson WA, Glode LM, Dantas ME, Koeppler H, Morton N, Sutherland J. Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study. Am J Clin Oncol. 1982 Dec; 5(6):611-22.
Score: 0.001
-
Bolin RW, Robinson WA, Sutherland J, Hamman RF. Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia. Cancer. 1982 Nov 01; 50(9):1683-6.
Score: 0.001
-
Hartmann DW, Robinson WA, Morton NJ, Mangalik A, Glode LM. High-dose nitrogen mustard (HN2) with autologous nonfrozen bone marrow transplantation in advanced malignant melanoma. A phase I trial. Blut. 1981 Apr; 42(4):209-20.
Score: 0.001
-
Hartmann DW, Robinson WA, Mangalik A, Glode LM, Triebel F. Unanticipated side effects from treatment with high-dose mechlorethamine in patients with malignant melanoma. Cancer Treat Rep. 1981 Mar-Apr; 65(3-4):327-8.
Score: 0.001
-
Mahmood T, Robinson WA, Hamstra RD, Wallner SF. Macrocytic anemia, thrombocytosis and nonlobulated megakaryocytes: the 5q-syndrome, a distinct entity. Am J Med. 1979 Jun; 66(6):946-50.
Score: 0.001
-
Mahmood T, Robinson WA, Entringer M. Autologous bone-marrow and peripheral blood buffy coat cell infusion in the treatment of chronic myeloid and acute leukemia. Exp Hematol. 1979; 7 Suppl 5:321-6.
Score: 0.001
-
Petersen CD, Robinson WA, Kurnick JE. Involvement of the heart and pericardium in the malignant lymphomas. Am J Med Sci. 1976 Sep-Oct; 272(2):161-5.
Score: 0.001
-
Gupta RC, Robinson WA, Kurnick JE. Felty's syndrome. Effect of lithium on granulopoiesis. Am J Med. 1976 Jul; 61(1):29-32.
Score: 0.001
-
Gupta R, Robinson WA, Albrecht D. Granulopoietic activity in Felty's syndrome. Ann Rheum Dis. 1975 Apr; 34(2):156-61.
Score: 0.000
-
Gupta RC, Robinson WA, Smyth CJ. Efficacy of lithium in rheumatoid arthritis with granulocytopenia (felty's syndrome). A preliminary report. Arthritis Rheum. 1975 Mar-Apr; 18(2):179-84.
Score: 0.000
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|